Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT06063850

AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy

The main goals of this clinical study are to learn if AMT-260 is safe and tolerable and works to reduce the frequency of seizures in adults with unilateral mesi…

United States12 participantsStarted 2024-06-12

Treatment: AAV9-hSyn1-miGRIK2

All recent trials (3 shown)

Not Yet RecruitingNot Applicable

NCT06558864

High Selective Subiculum SEEG Guided RF-TC for mTLE-HS

The primary objective of this research is to study the efficacy and safety of Stereotactic EEG (SEEG) guided radio-frequency thermocoagulation (RF-TC) of Subicu…

Location not specified20 participantsStarted 2024-08-09

Treatment: Subiculum RF-TC

CompletedNot Applicable

NCT03941613

SEEG Guided RF-TC v.s. ATL for mTLE With HS

Mesial temporal lobe epilepsy (mTLE) is the most classical subtype of temporal lobe epilepsy, which is the indication of surgical intervention after evaluation.…

China40 participantsStarted 2019-08-05

Treatment: SEEG guided RF-TC, Anterior temporal lobectomy